Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight According to DelveInsight’s analysis, the market for ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years.

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.

13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations ... and Drug Administration to treat gastrointestinal stromal tumors ... Mar. 10, 2025 — In a study ...

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

Researchers explore the role of a high-fat diet in promoting the formation of premetastatic niches and platelet activation.

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.